剪切波弹性成像病灶-脂肪弹性比值可减少BI-RADS 4乳腺良性活检
该研究为国际多中心诊断试验的二次分析,纳入1288例常规超声BI-RADS 3或4a-c乳腺病灶,评估剪切波弹性成像病灶-脂肪弹性比值在BI-RADS 4a病灶中以1.85为阈值重新分类,可使良性活检减少44.04%,同时遗漏1.98%恶性肿瘤,仍符合ACR BI-RADS 3的<2%未检出恶性肿瘤定义。
要点
- BI-RADS 4a乳腺病灶加用病灶-脂肪弹性比值(阈值1.85)可减少44.04%良性活检。
- 重新分类后遗漏1.98%恶性肿瘤,仍符合BI-RADS 3的<2%未检出恶性肿瘤标准。
- 常规超声将53.8%病理良性病灶归为BI-RADS 4,存在较高假阳性。
核心结论
- 在BI-RADS 4a乳腺病灶中,常规B型超声加用剪切波弹性成像病灶-脂肪弹性比值(阈值1.85)可使良性活检减少44.04%,同时遗漏1.98%恶性肿瘤,仍符合ACR BI-RADS 3的<2%未检出恶性肿瘤定义。
研究设计与样本
- 研究为国际诊断性多中心试验(NCT02638935)的二次分析,纳入1288例常规B型超声分类为BI-RADS 3和4a-c的乳腺病灶女性,重点区分BI-RADS 3与4a。
- 所有患者均接受剪切波弹性成像检查,并以组织病理学评估为参考标准。
诊断标准与关键数值
- 剪切波弹性成像病灶-脂肪弹性比值用于BI-RADS 4a病灶的截断值为1.85。
- 常规B型超声将53.8%(495/1288)病理良性病灶归为BI-RADS 4,假阳性率为53.8%。
- 常规B型超声将1.39%(6/431)恶性肿瘤归为BI-RADS 3,未检出恶性肿瘤率为1.39%。
- 加用病灶-脂肪弹性比值(阈值1.85)后,30.11%的良性病灶接受活检,对应假阳性减少44.04%。
- 重新分类后遗漏1.98%恶性肿瘤,仍符合ACR BI-RADS 3定义的<2%未检出恶性肿瘤。
临床应用与阅片要点
- 对常规超声BI-RADS 4a乳腺病灶,可考虑加用剪切波弹性成像病灶-脂肪弹性比值(阈值1.85)辅助决策,以减少不必要的良性活检。
- 应用该比值重新分类时需注意可能遗漏约1.98%恶性肿瘤,应结合临床及其他影像特征综合判断。
局限性
- 本研究为二次分析,重点仅放在区分BI-RADS 3与4a病灶,结论外推至其他BI-RADS亚类需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: We evaluated whether lesion-to-fat ratio measured by shear wave elastography in patients with Breast Imaging Reporting and Data System (BI-RADS) 3 or 4 lesions has the potential to further refine the assessment of B-mode ultrasound alone in breast cancer diagnostics.
METHODS: This was a secondary analysis of an international diagnostic multicenter trial (NCT02638935). Data from 1288 women with breast lesions categorized as BI-RADS 3 and 4a-c by conventional B-mode ultrasound were analyzed, whereby the focus was placed on differentiating lesions categorized as BI-RADS 3 and BI-RADS 4a. All women underwent shear wave elastography and histopathologic evaluation functioning as reference standard. Reduction of benign biopsies as well as the number of missed malignancies after reclassification using lesion-to-fat ratio measured by shear wave elastography were evaluated.
RESULTS: Breast cancer was diagnosed in 368 (28.6%) of 1288 lesions. The assessment with conventional B-mode ultrasound resulted in 53.8% (495 of 1288) pathologically benign lesions categorized as BI-RADS 4 and therefore false positives as well as in 1.39% (6 of 431) undetected malignancies categorized as BI-RADS 3. Additional lesion-to-fat ratio in BI-RADS 4a lesions with a cutoff value of 1.85 resulted in 30.11% biopsies of benign lesions which correspond to a reduction of 44.04% of false positives.
CONCLUSIONS: Adding lesion-to-fat ratio measured by shear wave elastography to conventional B-mode ultrasound in BI-RADS 4a breast lesions could help reduce the number of benign biopsies by 44.04%. At the same time, however, 1.98% of malignancies were missed, which would still be in line with American College of Radiology BI-RADS 3 definition of <2% of undetected malignancies.
引用
- Togawa, Pfob, Büsch, et al. Potential of Lesion-to-Fat Elasticity Ratio Measured by Shear Wave Elastography to Reduce Benign Biopsies in BI-RADS 4 Breast Lesions. J Ultrasound Med. 2023. PMID: 36789976. doi:10.1002/jum.16192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。